Knowledge Center

Article / 2017

Expanding the Commercial Options

Expanding the Commercial Options for Preparation of Amorphous Solid Dispersions

Authors:
  • Marcio Temtem
  • Joao Vicente
Source:
Pharma's Almanac, Q1 2017, Mar 8, 2017

Spray drying (SD) and hot-melt extrusion (HME) are commercially proven and accepted amorphous solid dispersion (ASD) technologies for the enhancement of the dissolution and bioavailability of poorly soluble drugs. These approaches are not suitable for all APIs, however. Hovione, in addition to offering non-ASD solutions such as nanomilling and cyclodextrin complexation, is developing an effective coprecipitation technology platform to address this key market need.

Read the full article

Related links

Read the full article

Also in the Knowledge Center

Related content

Dispersome®

Make your drug soluble with Dispersome® technology. Dispersome® is a solubility enhancement technology that relies on an innovative and naturally occurring excipient to develop amorphous solid dispersions with high drug loading and high bioavailability.

Page
Read more

Hot melt extrusion

Hot melt extrusion is a fast growing technology platform thas is utilized to solve difficult formulation challenges, primarily in the area of solubilization.

Page
Read more